RecruitingPhase 1Phase 2NCT06780267

Clinical Study of HRS-2129 for Postoperative Analgesia in Orthopaedics

Clinical Study on Safety and Efficacy of HRS-2129 for Postoperative Analgesiain Orthopaedics

Sponsor

Shandong Suncadia Medicine Co., Ltd.

Enrollment

195 participants

Start Date

Mar 11, 2025

Study Type

INTERVENTIONAL

Conditions

Postoperative Pain in Orthopaedics

Summary

The study is being conducted to evaluate the safety, and efficacy of HRS-2129 for Postoperative analgesia in orthopaedics. To explore the reasonable dosage of HRS-2129 for Postoperative analgesia in orthopaedics.

Eligibility

Min Age: 18 Years

Plain Language Summary

Simplified for easier understanding

This clinical trial is studying a drug called HRS-2129, a drug called HRS-2129 placebo, and others for people with postoperative pain in orthopaedics. The study is currently recruiting participants at 1 location. People eligible for this study include aged 18 Years and older.

This summary was AI-generated to explain the trial in plain language. It is not medical advice. Always discuss eligibility with your doctor before enrolling in a clinical trial.

Interested in this trial?

Get notified about updates and connect with the research team.

Interventions

DRUGHRS-2129

HRS-2129

DRUGHRS-2129 placebo

HRS-2129 placebo

DRUGTramadol Hydrochloride SR Tablets

Tramadol Hydrochloride SR Tablets

Locations(1)

Sichuan Academy of Medical Sciences - Sichuan Provincial People's Hospital

Chengdu, Sichuan, China

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT06780267